A new strategy for dealing with rheumatoid arthritis has been developed by researchers from RTI International University, North Carolina.
According to their report, combining a well-known synthetic disease-modifying antirheumatic drugs with one of six biologic medications often works best to reduce the joint swelling and tenderness associated with the condition.
Dr Carolyn Clancy, director of the Agency for Healthcare Quality and Research which funded the research said: "Rheumatoid arthritis is a painful, degenerative disease that affects people of all ages and can profoundly impact quality of life.
"This report establishes a clear, unbiased summary of what is known about current treatments. It also identifies areas where more research is needed."
There is currently no cure for rheumatoid arthritis, an inflammatory disease which can cause pain and loss of strength in the inflamed joints, stiffness and generally feeling unwell.
Meanwhile, British drug retailers have suspended the licence of arthritis drug Prexige amid fears that it has adverse effects on the liver.
Please click here for advice to help you find the right type of care.